Category Archives: Business

30Apr/21

Infinite Opportunities from Infinite Data in Life-Sciences

Siemens Announcements at the Hannover Messe 2021 – Event Brief

By Eric M. Luyer – Industry Research Analyst, Axendia Inc.

In these difficult “Corona” times the buzz word is “virtual”. Everything is virtual: meetings, webinars, education and conferences. A major yearly event is the Hannover Messe, Germany.  The event is a showcase and catalyst for the future of industrial transformation …and for 2021 it was virtual.

I had the opportunity to cover the first digital edition of the Hannover Messe from 12-16 April 2021.  According to Dr. Jochen Köckler, CEO of Deutsche Mess AG:  “The Hannover Messe 2021 Digital Edition demonstrates the innovative power of mechanical and electrical engineering and IT companies. At the same time, it showed that the tradeshow of the future is hybrid.”  And mentioned by the event organizers, 90,000 attendees generated more than 650,000 exhibitor and product searches during the five live trade show days.

This event is a showcase for all industries that are part of the industrial evolution.  It highlighted digital transformation processes necessary to meet requirements of sustainability and climate-neutral production, mobility of tomorrow and intelligent production and logistics technologies.  

This Event Brief reviews some of the exciting developments presented by Siemens A.G. during this virtual conference and how they might impact Life Sciences companies’ complex requirements now and in the future.

Continue reading
14Apr/21

Q: Who is the Best Technology Vendor? A: NONE!

An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings

By: Daniel R. Matlis

As a Life-Science Industry Analyst, I am often asked by executives to recommend the best technology vendor.

My standard answer:  None, there is no such thing as a “best vendor.”   

Just like an automotive industry analyst could not recommend the “best car” for you until they know your budget, unique requirements, and primary use; a Life Science industry analyst must understand your company’s intended use, business, regulatory and technology requirements, as well as organizational culture before recommending a system.

Yet for decades, Life-Science industry executives have relied on forced rankings from analyst firms to identify the top five vendors to invite for an RFP.  This is especially true when evaluating the alphabet soup of system acronyms (AI/ML, APS, CTMS, CM&S, EAM, EDC, ERP, LIMS, MES, PLM, RIM, SCM, etc., etc., etc.)

Continue reading
31Mar/21

Pfizer Uses Positive Disruption to Manage Product Design Across the Lifecycle

COVID-19 forced Life-Science companies to reimagine the way they operate. Pfizer has adapted its Culture, Systems and Processes to drive increased visibility, control and collaboration that have achieved unprecedented results.


Join Pfizer’s Hugo Felix and Axendia’s Daniel R. Matlis for a “Straight from the Source” live webinar on 21-APR-2021 at 11:30 AM ET as they discuss how Pfizer is using Positive Disruption to manage product design across the lifecycle.

31Mar/21

Improving Product Quality & Patient Outcomes with Integrated QRM

An Axendia Insight Brief, Presented by Sparta Systems

An effective Quality and Risk Management program enables Life Science manufacturers to proactively manage product quality and patient safety. Risk management is a top priority for regulators around the world with a special focus on combination products and medical devices.

Through the use of an integrated Quality and Risk Management approach, manufacturers can achieve maximum value from their Risk Management program by deeply integrating it to their Quality Management System. In doing so, Life Science manufacturers can unlock process efficiency and enhanced signal and trend detection, leading to improved product quality and reduced patient risk. 

This Insight Brief, presented by Sparta Systems, delves into key points of an integrated Quality Risk Management solution where the ultimate result is improved safety and product quality, driving better outcomes.

To learn how an integrated Quality and Risk Management program can maximize the use of QMS data supporting enhanced Risk Management and mitigation and improved product quality that delivers the maximum benefit to the patient, register to request your copy below.

25Mar/21

AVEVA to Accelerate Growth in Life-Sciences with OSIsoft Acquisition

AVEVA Briefing Note

By Daniel R. Matlis

Axendia was recently briefed by Craig Hayman, CEO AVEVA and Dr. J. Patrick Kennedy, Founder and Chairman Emeritus of OSIsoft and their executive team on AVEVA’s completed acquisition of OSIsoft, and the implications to the Life-Sciences industry.

The combined portfolio brings OSIsoft’s data management together with AVEVA’s industrial software with a joint focus on unlocking “Performance Intelligence.”

Source: AVEVA
Continue reading